On July 20, MicroPort MedBot-B rose 5.08% in regular trading, trading at HK$21.08/share, with turnover of HK$106 million. The stock rebounded after plunging 17.11% in the previous trading session.

The recovery was primarily driven by a broad-based rebound in the Health Care Equipment sector, with peers including COFOE Medical up 5.85%, Angelalign up 5.24%, and MicroPort Medical up 4.65%, indicating strong sector linkage. The bounce also comes against the backdrop of several recent commercialization milestones for the company's core Toumai laparoscopic surgical robot, including surpassing 300 global commercial orders, completing its 200th commercial installation at Spain's HM Hospitales, and obtaining the EU CE mark for its remote surgery application — making it the first remote surgical robot to receive such certification globally. The Toumai system has now achieved commercial installations in over 60 countries and regions, with first-half order volume already exceeding the full-year total for the prior year.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)